Bunge Ready to Report Q2 Earnings: What's in Store for the Stock?

Bunge Global SA (BG) is anticipated to report sharply lower Q2 2025 results on July 30, with Zacks Consensus Estimates projecting sales down 14.2% to $11.4 billion and earnings per share plunging 31.2% to $1.19. This expected underperformance is largely attributed to a significant projected decline in the Agribusiness segment's EBIT and the impact of the Sugar and Bioenergy segment's divestiture. The Zacks model does not conclusively predict an earnings beat for BG, whose shares have already fallen 29.7% over the past year, underperforming its industry.

Analysis

Bunge Global SA (BG) is positioned for a significantly weak second quarter, with consensus estimates pointing to a 14.2% year-over-year revenue decline to $11.4 billion and a 31.2% plunge in earnings per share to $1.19. The primary driver of this anticipated underperformance is substantial weakness in its core Agribusiness segment, where revenues are projected to fall 19.7% and adjusted EBIT is expected to drop 32% to $202 million, largely due to poor performance in North American and European softseeds. Other segments show signs of pressure as well; the Refined and Specialty Oils division forecasts a 28.2% drop in operating income despite a minor revenue increase, and the Milling segment's operating income is expected to decline 8.2% on higher raw material costs. Compounding these operational headwinds is the loss of income from the divested Sugar and Bioenergy segment. The stock's 29.7% price decline over the past year, which starkly underperforms the industry's 11.5% fall, reflects existing market pessimism, and the Zacks model's neutral signals (0.00% Earnings ESP) do not suggest a positive surprise is likely.

Key Decisions for Investors

• Given consensus estimates for a sharp decline in both revenue and earnings, particularly a 32% EBIT plunge in the core Agribusiness segment, a cautious or bearish stance is warranted heading into the July 30 report.
• Investors should scrutinize the actual performance of the Agribusiness segment against its projected $202 million EBIT and listen for management commentary on softseed processing margins, as this will be the primary catalyst for the stock's post-earnings movement.
• While the stock's significant year-over-year underperformance suggests much negativity is priced in, attention should be on forward-looking guidance for any indication of margin stabilization or further deterioration in the second half of the year.